The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Candidiasis Drug Market Research Report 2025
Synopsis
The standard recommended dose for most Candida infections is fluconazole at 800 mg as the loading dose, followed by fluconazole at a dose of 400 mg/d either intravenously or orally for at least 2 weeks of therapy after a demonstrated negative blood culture result or clinical signs of improvement.
The global Candidiasis Drug market was valued at US$ 1163 million in 2023 and is anticipated to reach US$ 1617.6 million by 2030, witnessing a CAGR of 4.8% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Candidiasis Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Candidiasis Drug.
Report Scope
The Candidiasis Drug market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Candidiasis Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Candidiasis Drug companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bayer
Perrigo
J & J
Pfizer
Bristol-Myers Squibb
Effik
Teva
Sanofi
Cisen Pharmaceutical
Kingyork Group
Segment by Type
Oral
External Use
Other
Segment by Application
Hospital
Retail Pharmacy
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Candidiasis Drug companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The standard recommended dose for most Candida infections is fluconazole at 800 mg as the loading dose, followed by fluconazole at a dose of 400 mg/d either intravenously or orally for at least 2 weeks of therapy after a demonstrated negative blood culture result or clinical signs of improvement.
The global Candidiasis Drug market was valued at US$ 1163 million in 2023 and is anticipated to reach US$ 1617.6 million by 2030, witnessing a CAGR of 4.8% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Candidiasis Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Candidiasis Drug.
Report Scope
The Candidiasis Drug market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Candidiasis Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Candidiasis Drug companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bayer
Perrigo
J & J
Pfizer
Bristol-Myers Squibb
Effik
Teva
Sanofi
Cisen Pharmaceutical
Kingyork Group
Segment by Type
Oral
External Use
Other
Segment by Application
Hospital
Retail Pharmacy
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Candidiasis Drug companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Candidiasis Drug Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Oral
1.2.3 External Use
1.2.4 Other
1.3 Market by Application
1.3.1 Global Candidiasis Drug Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Retail Pharmacy
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Candidiasis Drug Market Perspective (2019-2030)
2.2 Candidiasis Drug Growth Trends by Region
2.2.1 Global Candidiasis Drug Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Candidiasis Drug Historic Market Size by Region (2019-2024)
2.2.3 Candidiasis Drug Forecasted Market Size by Region (2025-2030)
2.3 Candidiasis Drug Market Dynamics
2.3.1 Candidiasis Drug Industry Trends
2.3.2 Candidiasis Drug Market Drivers
2.3.3 Candidiasis Drug Market Challenges
2.3.4 Candidiasis Drug Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Candidiasis Drug Players by Revenue
3.1.1 Global Top Candidiasis Drug Players by Revenue (2019-2024)
3.1.2 Global Candidiasis Drug Revenue Market Share by Players (2019-2024)
3.2 Global Candidiasis Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Candidiasis Drug Revenue
3.4 Global Candidiasis Drug Market Concentration Ratio
3.4.1 Global Candidiasis Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Candidiasis Drug Revenue in 2023
3.5 Candidiasis Drug Key Players Head office and Area Served
3.6 Key Players Candidiasis Drug Product Solution and Service
3.7 Date of Enter into Candidiasis Drug Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Candidiasis Drug Breakdown Data by Type
4.1 Global Candidiasis Drug Historic Market Size by Type (2019-2024)
4.2 Global Candidiasis Drug Forecasted Market Size by Type (2025-2030)
5 Candidiasis Drug Breakdown Data by Application
5.1 Global Candidiasis Drug Historic Market Size by Application (2019-2024)
5.2 Global Candidiasis Drug Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Candidiasis Drug Market Size (2019-2030)
6.2 North America Candidiasis Drug Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Candidiasis Drug Market Size by Country (2019-2024)
6.4 North America Candidiasis Drug Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Candidiasis Drug Market Size (2019-2030)
7.2 Europe Candidiasis Drug Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Candidiasis Drug Market Size by Country (2019-2024)
7.4 Europe Candidiasis Drug Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Candidiasis Drug Market Size (2019-2030)
8.2 Asia-Pacific Candidiasis Drug Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Candidiasis Drug Market Size by Region (2019-2024)
8.4 Asia-Pacific Candidiasis Drug Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Candidiasis Drug Market Size (2019-2030)
9.2 Latin America Candidiasis Drug Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Candidiasis Drug Market Size by Country (2019-2024)
9.4 Latin America Candidiasis Drug Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Candidiasis Drug Market Size (2019-2030)
10.2 Middle East & Africa Candidiasis Drug Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Candidiasis Drug Market Size by Country (2019-2024)
10.4 Middle East & Africa Candidiasis Drug Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Bayer
11.1.1 Bayer Company Detail
11.1.2 Bayer Business Overview
11.1.3 Bayer Candidiasis Drug Introduction
11.1.4 Bayer Revenue in Candidiasis Drug Business (2019-2024)
11.1.5 Bayer Recent Development
11.2 Perrigo
11.2.1 Perrigo Company Detail
11.2.2 Perrigo Business Overview
11.2.3 Perrigo Candidiasis Drug Introduction
11.2.4 Perrigo Revenue in Candidiasis Drug Business (2019-2024)
11.2.5 Perrigo Recent Development
11.3 J & J
11.3.1 J & J Company Detail
11.3.2 J & J Business Overview
11.3.3 J & J Candidiasis Drug Introduction
11.3.4 J & J Revenue in Candidiasis Drug Business (2019-2024)
11.3.5 J & J Recent Development
11.4 Pfizer
11.4.1 Pfizer Company Detail
11.4.2 Pfizer Business Overview
11.4.3 Pfizer Candidiasis Drug Introduction
11.4.4 Pfizer Revenue in Candidiasis Drug Business (2019-2024)
11.4.5 Pfizer Recent Development
11.5 Bristol-Myers Squibb
11.5.1 Bristol-Myers Squibb Company Detail
11.5.2 Bristol-Myers Squibb Business Overview
11.5.3 Bristol-Myers Squibb Candidiasis Drug Introduction
11.5.4 Bristol-Myers Squibb Revenue in Candidiasis Drug Business (2019-2024)
11.5.5 Bristol-Myers Squibb Recent Development
11.6 Effik
11.6.1 Effik Company Detail
11.6.2 Effik Business Overview
11.6.3 Effik Candidiasis Drug Introduction
11.6.4 Effik Revenue in Candidiasis Drug Business (2019-2024)
11.6.5 Effik Recent Development
11.7 Teva
11.7.1 Teva Company Detail
11.7.2 Teva Business Overview
11.7.3 Teva Candidiasis Drug Introduction
11.7.4 Teva Revenue in Candidiasis Drug Business (2019-2024)
11.7.5 Teva Recent Development
11.8 Sanofi
11.8.1 Sanofi Company Detail
11.8.2 Sanofi Business Overview
11.8.3 Sanofi Candidiasis Drug Introduction
11.8.4 Sanofi Revenue in Candidiasis Drug Business (2019-2024)
11.8.5 Sanofi Recent Development
11.9 Cisen Pharmaceutical
11.9.1 Cisen Pharmaceutical Company Detail
11.9.2 Cisen Pharmaceutical Business Overview
11.9.3 Cisen Pharmaceutical Candidiasis Drug Introduction
11.9.4 Cisen Pharmaceutical Revenue in Candidiasis Drug Business (2019-2024)
11.9.5 Cisen Pharmaceutical Recent Development
11.10 Kingyork Group
11.10.1 Kingyork Group Company Detail
11.10.2 Kingyork Group Business Overview
11.10.3 Kingyork Group Candidiasis Drug Introduction
11.10.4 Kingyork Group Revenue in Candidiasis Drug Business (2019-2024)
11.10.5 Kingyork Group Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Candidiasis Drug Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Oral
Table 3. Key Players of External Use
Table 4. Key Players of Other
Table 5. Global Candidiasis Drug Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Candidiasis Drug Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Candidiasis Drug Market Size by Region (2019-2024) & (US$ Million)
Table 8. Global Candidiasis Drug Market Share by Region (2019-2024)
Table 9. Global Candidiasis Drug Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 10. Global Candidiasis Drug Market Share by Region (2025-2030)
Table 11. Candidiasis Drug Market Trends
Table 12. Candidiasis Drug Market Drivers
Table 13. Candidiasis Drug Market Challenges
Table 14. Candidiasis Drug Market Restraints
Table 15. Global Candidiasis Drug Revenue by Players (2019-2024) & (US$ Million)
Table 16. Global Candidiasis Drug Market Share by Players (2019-2024)
Table 17. Global Top Candidiasis Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Candidiasis Drug as of 2023)
Table 18. Ranking of Global Top Candidiasis Drug Companies by Revenue (US$ Million) in 2023
Table 19. Global 5 Largest Players Market Share by Candidiasis Drug Revenue (CR5 and HHI) & (2019-2024)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Candidiasis Drug Product Solution and Service
Table 22. Date of Enter into Candidiasis Drug Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Candidiasis Drug Market Size by Type (2019-2024) & (US$ Million)
Table 25. Global Candidiasis Drug Revenue Market Share by Type (2019-2024)
Table 26. Global Candidiasis Drug Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 27. Global Candidiasis Drug Revenue Market Share by Type (2025-2030)
Table 28. Global Candidiasis Drug Market Size by Application (2019-2024) & (US$ Million)
Table 29. Global Candidiasis Drug Revenue Market Share by Application (2019-2024)
Table 30. Global Candidiasis Drug Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 31. Global Candidiasis Drug Revenue Market Share by Application (2025-2030)
Table 32. North America Candidiasis Drug Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 33. North America Candidiasis Drug Market Size by Country (2019-2024) & (US$ Million)
Table 34. North America Candidiasis Drug Market Size by Country (2025-2030) & (US$ Million)
Table 35. Europe Candidiasis Drug Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 36. Europe Candidiasis Drug Market Size by Country (2019-2024) & (US$ Million)
Table 37. Europe Candidiasis Drug Market Size by Country (2025-2030) & (US$ Million)
Table 38. Asia-Pacific Candidiasis Drug Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 39. Asia-Pacific Candidiasis Drug Market Size by Region (2019-2024) & (US$ Million)
Table 40. Asia-Pacific Candidiasis Drug Market Size by Region (2025-2030) & (US$ Million)
Table 41. Latin America Candidiasis Drug Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 42. Latin America Candidiasis Drug Market Size by Country (2019-2024) & (US$ Million)
Table 43. Latin America Candidiasis Drug Market Size by Country (2025-2030) & (US$ Million)
Table 44. Middle East & Africa Candidiasis Drug Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 45. Middle East & Africa Candidiasis Drug Market Size by Country (2019-2024) & (US$ Million)
Table 46. Middle East & Africa Candidiasis Drug Market Size by Country (2025-2030) & (US$ Million)
Table 47. Bayer Company Detail
Table 48. Bayer Business Overview
Table 49. Bayer Candidiasis Drug Product
Table 50. Bayer Revenue in Candidiasis Drug Business (2019-2024) & (US$ Million)
Table 51. Bayer Recent Development
Table 52. Perrigo Company Detail
Table 53. Perrigo Business Overview
Table 54. Perrigo Candidiasis Drug Product
Table 55. Perrigo Revenue in Candidiasis Drug Business (2019-2024) & (US$ Million)
Table 56. Perrigo Recent Development
Table 57. J & J Company Detail
Table 58. J & J Business Overview
Table 59. J & J Candidiasis Drug Product
Table 60. J & J Revenue in Candidiasis Drug Business (2019-2024) & (US$ Million)
Table 61. J & J Recent Development
Table 62. Pfizer Company Detail
Table 63. Pfizer Business Overview
Table 64. Pfizer Candidiasis Drug Product
Table 65. Pfizer Revenue in Candidiasis Drug Business (2019-2024) & (US$ Million)
Table 66. Pfizer Recent Development
Table 67. Bristol-Myers Squibb Company Detail
Table 68. Bristol-Myers Squibb Business Overview
Table 69. Bristol-Myers Squibb Candidiasis Drug Product
Table 70. Bristol-Myers Squibb Revenue in Candidiasis Drug Business (2019-2024) & (US$ Million)
Table 71. Bristol-Myers Squibb Recent Development
Table 72. Effik Company Detail
Table 73. Effik Business Overview
Table 74. Effik Candidiasis Drug Product
Table 75. Effik Revenue in Candidiasis Drug Business (2019-2024) & (US$ Million)
Table 76. Effik Recent Development
Table 77. Teva Company Detail
Table 78. Teva Business Overview
Table 79. Teva Candidiasis Drug Product
Table 80. Teva Revenue in Candidiasis Drug Business (2019-2024) & (US$ Million)
Table 81. Teva Recent Development
Table 82. Sanofi Company Detail
Table 83. Sanofi Business Overview
Table 84. Sanofi Candidiasis Drug Product
Table 85. Sanofi Revenue in Candidiasis Drug Business (2019-2024) & (US$ Million)
Table 86. Sanofi Recent Development
Table 87. Cisen Pharmaceutical Company Detail
Table 88. Cisen Pharmaceutical Business Overview
Table 89. Cisen Pharmaceutical Candidiasis Drug Product
Table 90. Cisen Pharmaceutical Revenue in Candidiasis Drug Business (2019-2024) & (US$ Million)
Table 91. Cisen Pharmaceutical Recent Development
Table 92. Kingyork Group Company Detail
Table 93. Kingyork Group Business Overview
Table 94. Kingyork Group Candidiasis Drug Product
Table 95. Kingyork Group Revenue in Candidiasis Drug Business (2019-2024) & (US$ Million)
Table 96. Kingyork Group Recent Development
Table 97. Research Programs/Design for This Report
Table 98. Key Data Information from Secondary Sources
Table 99. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Candidiasis Drug Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Candidiasis Drug Market Share by Type: 2023 VS 2030
Figure 3. Oral Features
Figure 4. External Use Features
Figure 5. Other Features
Figure 6. Global Candidiasis Drug Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Candidiasis Drug Market Share by Application: 2023 VS 2030
Figure 8. Hospital Case Studies
Figure 9. Retail Pharmacy Case Studies
Figure 10. Other Case Studies
Figure 11. Candidiasis Drug Report Years Considered
Figure 12. Global Candidiasis Drug Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 13. Global Candidiasis Drug Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Candidiasis Drug Market Share by Region: 2023 VS 2030
Figure 15. Global Candidiasis Drug Market Share by Players in 2023
Figure 16. Global Top Candidiasis Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Candidiasis Drug as of 2023)
Figure 17. The Top 10 and 5 Players Market Share by Candidiasis Drug Revenue in 2023
Figure 18. North America Candidiasis Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 19. North America Candidiasis Drug Market Share by Country (2019-2030)
Figure 20. United States Candidiasis Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Canada Candidiasis Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Candidiasis Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Candidiasis Drug Market Share by Country (2019-2030)
Figure 24. Germany Candidiasis Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. France Candidiasis Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. U.K. Candidiasis Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Italy Candidiasis Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Russia Candidiasis Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Nordic Countries Candidiasis Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Candidiasis Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Candidiasis Drug Market Share by Region (2019-2030)
Figure 32. China Candidiasis Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Japan Candidiasis Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. South Korea Candidiasis Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Southeast Asia Candidiasis Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. India Candidiasis Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Australia Candidiasis Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Candidiasis Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Candidiasis Drug Market Share by Country (2019-2030)
Figure 40. Mexico Candidiasis Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Brazil Candidiasis Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Candidiasis Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Candidiasis Drug Market Share by Country (2019-2030)
Figure 44. Turkey Candidiasis Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Saudi Arabia Candidiasis Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Bayer Revenue Growth Rate in Candidiasis Drug Business (2019-2024)
Figure 47. Perrigo Revenue Growth Rate in Candidiasis Drug Business (2019-2024)
Figure 48. J & J Revenue Growth Rate in Candidiasis Drug Business (2019-2024)
Figure 49. Pfizer Revenue Growth Rate in Candidiasis Drug Business (2019-2024)
Figure 50. Bristol-Myers Squibb Revenue Growth Rate in Candidiasis Drug Business (2019-2024)
Figure 51. Effik Revenue Growth Rate in Candidiasis Drug Business (2019-2024)
Figure 52. Teva Revenue Growth Rate in Candidiasis Drug Business (2019-2024)
Figure 53. Sanofi Revenue Growth Rate in Candidiasis Drug Business (2019-2024)
Figure 54. Cisen Pharmaceutical Revenue Growth Rate in Candidiasis Drug Business (2019-2024)
Figure 55. Kingyork Group Revenue Growth Rate in Candidiasis Drug Business (2019-2024)
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
